Company News

Share this article:

Roche sued Mylan to prevent the latter from marketing a generic version of its Xeloda breast cancer treatment. According to a Bloomberg report, Xeloda pulled in over $1 billion in sales last year. The drug is also indicated as a treatment for colon cancer following surgery.

 

Spectrum Science Communications, a Washington DC-based health and science communications firm, is refining its name and rebranding itself as Spectrum. The company opened an office in New York, and has invested resources in digital media, consumer marketing and health policy, and added a research partner.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.